Schedule 13G ownership disclosure

Salarius Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 79400X107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
58,819
Percent of class
1.4500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-20-000127
Form type
SC 13G/A
Filer
RENAISSANCE TECHNOLOGIES LLC
CIK
CIK 1037389
Filed
Feb 13, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub